A
APT Medical Inc
SSE:688617
APT Medical Inc
SSE:688617
Price:
390
CNY
-0.76%
Market Closed
Market Cap:
37.9B
CNY
Income Statement
Earnings Waterfall
APT Medical Inc
APT Medical Inc
|
Revenue
|
2B
CNY
|
|
Cost of Revenue
|
-566.2m
CNY
|
|
Gross Profit
|
1.4B
CNY
|
|
Operating Expenses
|
-680.7m
CNY
|
|
Operating Income
|
714.5m
CNY
|
|
Other Expenses
|
-55.6m
CNY
|
|
Net Income
|
658.8m
CNY
|
Income Statement
APT Medical Inc
APT Medical Inc
Currency: CNY
Millions
TTM
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||
| Revenue |
933
N/A
|
1 000
+7%
|
1 123
+12%
|
1 216
+8%
|
1 300
+7%
|
1 448
+11%
|
1 542
+6%
|
1 650
+7%
|
1 756
+6%
|
1 863
+6%
|
1 961
+5%
|
|
| Gross Profit | ||||||||||||
| Cost of Revenue |
(295)
|
(313)
|
(344)
|
(354)
|
(388)
|
(426)
|
(459)
|
(486)
|
(520)
|
(546)
|
(566)
|
|
| Gross Profit |
638
N/A
|
687
+8%
|
778
+13%
|
862
+11%
|
913
+6%
|
1 022
+12%
|
1 083
+6%
|
1 164
+7%
|
1 235
+6%
|
1 317
+7%
|
1 395
+6%
|
|
| Operating Income | ||||||||||||
| Operating Expenses |
(427)
|
(453)
|
(484)
|
(478)
|
(491)
|
(536)
|
(556)
|
(590)
|
(637)
|
(651)
|
(681)
|
|
| Selling, General & Administrative |
(278)
|
(286)
|
(306)
|
(307)
|
(323)
|
(349)
|
(371)
|
(384)
|
(412)
|
(425)
|
(430)
|
|
| Research & Development |
(158)
|
(173)
|
(188)
|
(162)
|
(183)
|
(195)
|
(209)
|
(219)
|
(251)
|
(263)
|
(272)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
(29)
|
0
|
0
|
0
|
(41)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
9
|
6
|
10
|
19
|
15
|
8
|
24
|
55
|
26
|
38
|
22
|
|
| Operating Income |
212
N/A
|
233
+10%
|
294
+26%
|
384
+30%
|
422
+10%
|
486
+15%
|
527
+9%
|
574
+9%
|
599
+4%
|
666
+11%
|
714
+7%
|
|
| Pre-Tax Income | ||||||||||||
| Interest Income Expense |
32
|
33
|
33
|
24
|
17
|
28
|
23
|
18
|
32
|
20
|
20
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
(11)
|
0
|
0
|
12
|
8
|
12
|
12
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
|
| Pre-Tax Income |
243
N/A
|
266
+10%
|
327
+23%
|
395
+21%
|
437
+11%
|
510
+17%
|
559
+10%
|
596
+7%
|
638
+7%
|
693
+9%
|
729
+5%
|
|
| Net Income | ||||||||||||
| Tax Provision |
(29)
|
(32)
|
(40)
|
(55)
|
(61)
|
(67)
|
(70)
|
(74)
|
(77)
|
(86)
|
(81)
|
|
| Income from Continuing Operations |
214
|
234
|
287
|
340
|
376
|
444
|
489
|
522
|
561
|
608
|
648
|
|
| Income to Minority Interest |
13
|
18
|
19
|
18
|
18
|
13
|
12
|
12
|
10
|
12
|
11
|
|
| Net Income (Common) |
228
N/A
|
252
+11%
|
306
+22%
|
358
+17%
|
394
+10%
|
457
+16%
|
501
+10%
|
534
+7%
|
571
+7%
|
619
+8%
|
659
+6%
|
|
| EPS (Diluted) |
3.41
N/A
|
3.77
+11%
|
4.59
+22%
|
3.7
-19%
|
5.83
+58%
|
6.82
+17%
|
5.08
-26%
|
5.53
+9%
|
5.82
+5%
|
6.4
+10%
|
6.7
+5%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
